Literature DB >> 7633873

Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse.

A E Evans1, J B Ruidavets, E E McCrum, J P Cambou, R McClean, P Douste-Blazy, D McMaster, A Bingham, C C Patterson, J L Richard.   

Abstract

The WHO MONICA project monitors trends and determinants in cardiovascular disease to relate classical risk factor changes to trends in incidence rates. The Belfast and Toulouse MONICA centres have also collaborated in dietary studies. Both centres have validated incidence and attack rates for ischaemic heart disease using coronary event registration. These data confirm that the disease in middle-aged men is between three and four times as common in Belfast as in Toulouse. Risk factor surveys show some differences between the centres, but the overall risks assessed by two multiple logistic function scoring systems were identical. A weighed dietary survey revealed no important difference in macronutrient intake, although carbohydrate and saturated fat intake in Belfast was significantly higher. Protein, dietary cholesterol and polyunsaturated fat, particularly linoleic acid intake, was significantly higher in Toulouse, as was consumption of wine, cheese, fruit and vegetables, but not potatoes. The Northern Irish diet is typically Northern European, but although the diet in Toulouse has some features of the Mediterranean diet, it is not appreciably different from that in Belfast in terms of total fat intake. Major differences are present for several food items, and in general these differences add support to the antioxidant hypothesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633873

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  15 in total

1.  Cholesterol: how low is low enough? Effect of a given concentration depends on several factors.

Authors:  A R Walker
Journal:  BMJ       Date:  1999-02-20

Review 2.  The French paradox: lessons for other countries.

Authors:  Jean Ferrières
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

3.  High consumptions of grain, fish, dairy products and combinations of these are associated with a low prevalence of metabolic syndrome.

Authors:  Jean-Bernard Ruidavets; Vanina Bongard; Jean Dallongeville; Dominique Arveiler; Pierre Ducimetière; Bertrand Perret; Chantal Simon; Philippe Amouyel; Jean Ferrières
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

4.  Types of alcoholic beverages and blood lipids in a French population.

Authors:  J-B Ruidavets; P Ducimetière; D Arveiler; P Amouyel; A Bingham; A Wagner; D Cottel; B Perret; J Ferrières
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

5.  Locally based surveys, unite! The EURALIM example. EURALIM Study Group. European Information Campaign on Diet and Nutrition.

Authors:  A Morabia; S Beer-Borst; S Hercberg
Journal:  Am J Public Health       Date:  1998-08       Impact factor: 9.308

6.  Hepatocellular carcinoma and african iron overload.

Authors:  A R Walker; I Segal
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

Review 7.  Shorter height is related to lower cardiovascular disease risk - a narrative review.

Authors:  Thomas T Samaras
Journal:  Indian Heart J       Date:  2012-12-26

Review 8.  News from Tartary: an ethnopharmacological approach to drug and therapeutic discovery.

Authors:  Nicholas Moore; Nawel Hamza; Benedicte Berke; Anwar Umar
Journal:  Br J Clin Pharmacol       Date:  2016-07-24       Impact factor: 4.335

9.  Food groups associated with a reduced risk of 15-year all-cause death.

Authors:  V Bongard; D Arveiler; J Dallongeville; J-B Ruidavets; A Wagner; C Simon; N Marécaux; J Ferrières
Journal:  Eur J Clin Nutr       Date:  2016-03-02       Impact factor: 4.016

10.  Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993.

Authors:  P Marques-Vidal; J B Ruidavets; J P Cambou; J Ferrières
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.